Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 27249-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- Neurofibromin 1 antibody
- Antibody type
- Polyclonal
- Description
- Neurofibromin 1 antibody (Cat. #27249-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma.
IGF2BP3 mediates the mRNA degradation of NF1 to promote triple-negative breast cancer progression via an m6A-dependent manner.
Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomas.
The oncogenic role of NF1 in gallbladder cancer through regulation of YAP1 stability by direct interaction with YAP1.
Characterization of Two Loss-of-Function NF1 Variants in Chinese Patients and Potential Molecular Interpretations of Phenotypes.
A novel mutation in NF1 gene of patient with Neurofibromatosis type 1: A case report and functional study.
Pucci P, Lee LC, Han M, Matthews JD, Jahangiri L, Schlederer M, Manners E, Sorby-Adams A, Kaggie J, Trigg RM, Steel C, Hare L, James ER, Prokoph N, Ducray SP, Merkel O, Rifatbegovic F, Luo J, Taschner-Mandl S, Kenner L, Burke GAA, Turner SD
Nature communications 2024 Apr 23;15(1):3422
Nature communications 2024 Apr 23;15(1):3422
IGF2BP3 mediates the mRNA degradation of NF1 to promote triple-negative breast cancer progression via an m6A-dependent manner.
Zhang X, Shi L, Sun HD, Wang ZW, Xu F, Wei JF, Ding Q
Clinical and translational medicine 2023 Sep;13(9):e1427
Clinical and translational medicine 2023 Sep;13(9):e1427
Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomas.
Köbel M, Yang RZ, Kang EY, Al-Shamma Z, Cook LS, Kinloch M, Carey MS, Hopkins L, Nelson GS, McManus KJ, Vizeacoumar FS, Vizeacoumar FJ, Freywald A, Fu Y, Reuss DE, Lee CH
Gynecologic oncology 2023 Nov;178:80-88
Gynecologic oncology 2023 Nov;178:80-88
The oncogenic role of NF1 in gallbladder cancer through regulation of YAP1 stability by direct interaction with YAP1.
Zhang L, Jiang L, Zeng L, Jin Z, Dong X, Zhang Y, Chen L, Shu Y, Liu Y, Huang Y
Journal of translational medicine 2023 May 5;21(1):306
Journal of translational medicine 2023 May 5;21(1):306
Characterization of Two Loss-of-Function NF1 Variants in Chinese Patients and Potential Molecular Interpretations of Phenotypes.
Zhang T, Han T, Dong Z, Li C, Lu W
Frontiers in genetics 2021;12:660592
Frontiers in genetics 2021;12:660592
A novel mutation in NF1 gene of patient with Neurofibromatosis type 1: A case report and functional study.
Zhang T, Jia C, Dong Z, Li C, Lu W
Molecular genetics & genomic medicine 2021 May;9(5):e1643
Molecular genetics & genomic medicine 2021 May;9(5):e1643
No comments: Submit comment
No validations: Submit validation data